[1]JournalofMedicinalChemistry,2011,vol.54,#15,p.5320-5334
[1]JournalofMedicinalChemistry,2011,vol.54,p.5320-5334
1373431-65-2 | (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate | AA00A0EU | MFCD31657366
1311315-75-9 | 1H-1,2,4-Triazole-3-propanamine, 5-cyclopropyl-, hydrochloride | AA00A0S1 | MFCD18483232
1361229-76-6 | CK2 inhibitor 10 | AA00A1CQ | MFCD28127268
131755-87-8 | Methyl 4-amino-3,5-diiodobenzoate | AA00A2H1 | MFCD00010874
1246088-36-7 | 5-Bromo-2-ethyl-1-(triisopropylsilyl)-1h-pyrrolo[2,3-b]pyridine | AA00A5FK | MFCD17171321
137870-76-9 | (S)-1-Benzoyl-2-methylpyrrolidine-2-carboxylic acid | AA00A90V | MFCD19381850
1262197-81-8 | Methyl 6-methoxy-5-(4-methyl-1H-imidazol-1-yl)pyridine-2-carboxylate | AA00AAAL | MFCD26936352
16630-56-1 | 1-Butanol, 3-(methylthio)- | AA00AAYV | MFCD00004899
172753-42-3 | 2-(Dimethylamino)-4-oxo-1,4-dihydroquinoline-3-carbaldehyde | AA00AB7S | MFCD00542233
1456858-58-4 | Hg-9-91-01 | AA00ABHK | MFCD28167714